Details for New Drug Application (NDA): 089179
✉ Email this page to a colleague
NDA 089179 describes BELDIN, which is a drug marketed by Halsey and is included in one NDA. Additional details are available on the BELDIN profile page.
The generic ingredient in BELDIN is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.
The generic ingredient in BELDIN is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.
Summary for 089179
| Tradename: | BELDIN |
| Applicant: | Halsey |
| Ingredient: | diphenhydramine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 089179
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYRUP;ORAL | Strength | 12.5MG/5ML | ||||
| Approval Date: | Jun 5, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
